CASI Pharmaceuticals

CASI is a biopharmaceutical company focused on the acquisition, development, and commercialization of innovative therapeutics addressing CANCER and other unmet medical needs for the global market, with a focus on China and the U.S. Our mission is to become an integrated biopharmaceutical company with significant market share in China, while establishing partnerships for global development and commercialization. Part of our strategy is to leverage our expertise and resources in North America and China to bring safer, more effective, and/or easier-to-use drugs to patients and to develop them more cost-effectively and faster using our unique dual development approach.
Rockville, US
20 (est)

CASI Pharmaceuticals Locations

Rockville, US
Beijing, CN

CASI Pharmaceuticals Metrics

CASI Pharmaceuticals Summary

Market capitalization

$81.3 M

Closing share price


CASI Pharmaceuticals Financials

FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015


$1.94 M$669 K

Cost of goods sold

$7.47 K$6.27 K

Interest expense

$10 M

CASI Pharmaceuticals Market Value History

CASI Pharmaceuticals News

CASI Pharmaceuticals Company Life

You may also be interested in